Abraham Ceesay Insider Profile
4 Followers
Abraham Ceesay, CEO, Director at Rapport Therapeutics, Inc., holds 569.64K shares in Rapport Therapeutics, Inc. (Ticker: RAPP), holds 2.38K shares in Charles River Labs (Ticker: CRL), holds ― shares in scPharmaceuticals (Ticker: SCPH).
Abraham Ceesay has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Abraham Ceesay holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Abraham Ceesay
Abraham Ceesay's Trading History
Rapport Therapeutics, Inc.
Aug 26, 2026
CEO, Director
Uninformative Sell
937.91K
$26.25M
Charles River Labs
May 11, 2026
Director
Uninformative Buy
255.42K
$669.33K
scPharmaceuticals
―
―
―
―
Cerevel Therapeutics Holdings
Sep 12, 2022
―
Uninformative Buy
253.00K
$0.00
Pacira Pharmaceuticals
Sep 08, 2025
Director
Uninformative Sell
64.01K
$233.84K
List of latest transactions for each holding click on a transaction to see Abraham Ceesay's performance on stock
You May Also Like
Abraham Ceesay insider profile FAQ
What is the percentage of profitable transactions made by Abraham Ceesay?
The percentage of profitable transactions made by Abraham Ceesay is ―.
What is the average return per transaction made by Abraham Ceesay?
The average return per transaction made by Abraham Ceesay is ―.
What stocks does Abraham Ceesay hold?
Abraham Ceesay holds: RAPP, CRL, SCPH, CERE, PCRX stocks.
What was Abraham Ceesay’s latest transaction?
Abraham Ceesay latest transaction was an Uninformative Sell of $937.91K.
What was Abraham Ceesay's most profitable transaction?
Abraham Ceesay’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Abraham Ceesay's role in Rapport Therapeutics, Inc.?
Abraham Ceesay's role in Rapport Therapeutics, Inc. is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.